Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.
Guardado en:
Autores principales: | Y. Anraku, H. Kuwahara, Y. Fukusato, A. Mizoguchi, T. Ishii, K. Nitta, Y. Matsumoto, K. Toh, K. Miyata, S. Uchida, K. Nishina, K. Osada, K. Itaka, N. Nishiyama, H. Mizusawa, T. Yamasoba, T. Yokota, K. Kataoka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fc143dfc7464c2e803e239b8d4ccb42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014) -
Effects of apolipoprotein E isoform, sex, and diet on insulin BBB pharmacokinetics in mice
por: Elizabeth M. Rhea, et al.
Publicado: (2021) -
Preparation and tumor cell model based biobehavioral evaluation of the nanocarrier system using partially reduced graphene oxide functionalized by surfactant
por: Wang Y, et al.
Publicado: (2015) -
Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases
por: Xingchi Chen, et al.
Publicado: (2021) -
Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis.
por: Panagiotis Papatheodorou, et al.
Publicado: (2010)